# Anavex Life Sciences (AVXL) — News

AVXL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/avxl/news

## Recent headlines

- [Alzheimer stocks rose in after-hours trading, with Anavex Life Sciences up 2.9%, while Alnylam Pharmaceuticals and BioMarin Pharmaceutical gained.](https://www.ainvest.com/news/alzheimer-stocks-rose-hours-trading-anavex-life-sciences-2-9-alnylam-pharmaceuticals-biomarin-pharmaceutical-gained-2610-45) — AInvest Wire, Oct 15, 2026
  Alzheimer's disease-related stocks saw gains in after-hours trading on October 15, 2026. Anavex Life Sciences (Nasdaq: AVXL) rose 2.9%, reflecting investor optimism about its pipeline of therapies targeting neurodegenerative conditions. Alnylam Pharmaceuticals (Nasdaq: ALNY) and BioMarin…
- [Anavex gets FDA clearance of IND application for blarcamesine](https://www.ainvest.com/news/anavex-fda-clearance-ind-application-blarcamesine-2610) — AInvest Wire, Oct 15, 2026
- [Alzheimer stocks rose in regular trading, with Eli Lilly up 4.3%, Anavex Life Sciences gaining 3.7% and Biogen rising 3.3%.](https://www.ainvest.com/news/alzheimer-stocks-rose-regular-trading-eli-lilly-4-3-anavex-life-sciences-gaining-3-7-biogen-rising-3-3-2610-18) — AInvest Wire, Oct 15, 2026
  Alzheimer’s-related stocks saw gains in regular trading on October 15, 2026, with Eli Lilly rising 4.3%, Anavex Life Sciences up 3.7%, and Biogen increasing by 3.3%. The movement reflects investor interest in the sector, particularly in companies advancing therapies for neurodegenerative diseases.…
- [Alzheimer stocks fell in intraday trading, with Eli Lilly down 4.5%, BioMarin Pharmaceutical down 4.5% and Anavex Life Sciences falling 4.1%.](https://www.ainvest.com/news/alzheimer-stocks-fell-intraday-trading-eli-lilly-4-5-biomarin-pharmaceutical-4-5-anavex-life-sciences-falling-4-1-2610-23) — AInvest Wire, Oct 8, 2026
  Alzheimer's-related stocks experienced a decline during intraday trading on October 8, 2026. Eli Lilly and BioMarin Pharmaceutical both fell by 4.5%, while Anavex Life Sciences dropped 4.1%. The downturn reflects broader market sentiment amid ongoing developments in the biotech and healthtech…
- [Anavex stockholders elect all of the company’s director nominees at 2026 annual meeting](https://www.ainvest.com/news/anavex-stockholders-elect-company-director-nominees-2026-annual-meeting-2609) — AInvest Wire, Sep 24, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).